BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23621864)

  • 1. Phospholipid Scramblase 1, an interferon-regulated gene located at 3q23, is regulated by SnoN/SkiL in ovarian cancer cells.
    Kodigepalli KM; Anur P; Spellman P; Sims PJ; Nanjundan M
    Mol Cancer; 2013 Apr; 12():32. PubMed ID: 23621864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SnoN/SkiL expression is modulated via arsenic trioxide-induced activation of the PI3K/AKT pathway in ovarian cancer cells.
    Kodigepalli KM; Dutta PS; Bauckman KA; Nanjundan M
    FEBS Lett; 2013 Jan; 587(1):5-16. PubMed ID: 23178716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells.
    Smith DM; Patel S; Raffoul F; Haller E; Mills GB; Nanjundan M
    Cell Death Differ; 2010 Dec; 17(12):1867-81. PubMed ID: 20508647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis.
    Nanjundan M; Cheng KW; Zhang F; Lahad J; Kuo WL; Schmandt R; Smith-McCune K; Fishman D; Gray JW; Mills GB
    Mol Oncol; 2008 Aug; 2(2):164-81. PubMed ID: 19383336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SnoN/SkiL, a TGFβ signaling mediator: a participant in autophagy induced by arsenic trioxide.
    Raffoul F; Campla C; Nanjundan M
    Autophagy; 2010 Oct; 6(7):955-7. PubMed ID: 20699661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers.
    Hagerstrand D; Tong A; Schumacher SE; Ilic N; Shen RR; Cheung HW; Vazquez F; Shrestha Y; Kim SY; Giacomelli AO; Rosenbluh J; Schinzel AC; Spardy NA; Barbie DA; Mermel CH; Weir BA; Garraway LA; Tamayo P; Mesirov JP; Beroukhim R; Hahn WC
    Cancer Discov; 2013 Sep; 3(9):1044-57. PubMed ID: 23764425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of PLSCR1 in a STING/IRF3-dependent manner upon vector transfection in ovarian epithelial cells.
    Kodigepalli KM; Nanjundan M
    PLoS One; 2015; 10(2):e0117464. PubMed ID: 25658875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiles of SnoN in normal and cancerous human tissues support its tumor suppressor role in human cancer.
    Jahchan NS; Ouyang G; Luo K
    PLoS One; 2013; 8(2):e55794. PubMed ID: 23418461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4.
    Tecalco-Cruz AC; Sosa-Garrocho M; Vázquez-Victorio G; Ortiz-García L; Domínguez-Hüttinger E; Macías-Silva M
    J Biol Chem; 2012 Aug; 287(32):26764-76. PubMed ID: 22674574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death.
    Choi HJ; Lui A; Ogony J; Jan R; Sims PJ; Lewis-Wambi J
    Breast Cancer Res; 2015 Jan; 17(1):6. PubMed ID: 25588716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of arsenic trioxide on proliferation and metastasis of drug-resistant human ovarian carcinoma cell line].
    Huang SG; Kong BH; Ma YY; Jiang S
    Ai Zheng; 2002 Aug; 21(8):863-7. PubMed ID: 12478894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of ovarian carcinoma cell growth in vivo by the interferon-inducible plasma membrane protein, phospholipid scramblase 1.
    Silverman RH; Halloum A; Zhou A; Dong B; Al-Zoghaibi F; Kushner D; Zhou Q; Zhao J; Wiedmer T; Sims PJ
    Cancer Res; 2002 Jan; 62(2):397-402. PubMed ID: 11809687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
    Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
    Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma.
    Mastorci K; Montico B; Faè DA; Sigalotti L; Ponzoni M; Inghirami G; Dolcetti R; Dal Col J
    Oncotarget; 2016 Jul; 7(27):41913-41928. PubMed ID: 27248824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SnoN/SKIL modulates proliferation through control of hsa-miR-720 transcription in esophageal cancer cells.
    Shinozuka E; Miyashita M; Mizuguchi Y; Akagi I; Kikuchi K; Makino H; Matsutani T; Hagiwara N; Nomura T; Uchida E; Takizawa T
    Biochem Biophys Res Commun; 2013 Jan; 430(1):101-6. PubMed ID: 23154181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of SnoN gene silencing by siRNA on the cell proliferation and apoptosis of human pancreatic cancer cells.
    Liu C; Zhang H; Zang X; Wang C; Kong Y; Zhang H
    Diagn Pathol; 2015 Apr; 10():30. PubMed ID: 25907906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing phospholipid scramblase 1 expression by RNA interference in colorectal cancer and metastatic liver cancer.
    Cui W; Li SY; Du JF; Zhu ZM; An P
    Hepatobiliary Pancreat Dis Int; 2012 Aug; 11(4):393-400. PubMed ID: 22893466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cells.
    Yuan Z; Wang F; Zhao Z; Zhao X; Qiu J; Nie C; Wei Y
    PLoS One; 2011; 6(5):e20586. PubMed ID: 21655183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide.
    Hour TC; Huang CY; Lin CC; Chen J; Guan JY; Lee JM; Pu YS
    Anticancer Drugs; 2004 Sep; 15(8):779-85. PubMed ID: 15494640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
    Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
    Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.